UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$541M |
| 2 |
Microsoft
MSFT
|
+$517M |
| 3 |
Meta Platforms (Facebook)
META
|
+$493M |
| 4 |
Willis Towers Watson
WTW
|
+$405M |
| 5 |
Amazon
AMZN
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$626M |
| 2 |
WORK
Slack Technologies, Inc.
WORK
|
+$282M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$217M |
| 4 |
Adobe
ADBE
|
+$201M |
| 5 |
Danaher
DHR
|
+$188M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.18% |
| 2 | Financials | 7.26% |
| 3 | Consumer Discretionary | 6.08% |
| 4 | Healthcare | 6.04% |
| 5 | Communication Services | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7826
Aligos Therapeutics
ALGS
$28.5M
| $11K | ﹤0.01% |
29
+15
| +107% | +$5.93K |
|
7827
Armata Pharmaceuticals
ARMP
$185M
| $11K | ﹤0.01% |
2,902
+1,436
| +98% | +$5.47K |
|
7828
Arts-Way Manufacturing Co
ARTW
$11.2M
| $11K | ﹤0.01% |
3,105
+1,717
| +124% | +$6.04K |
|
7829
Asure Software
ASUR
$253M
| $11K | ﹤0.01% |
1,307
-358
| -22% | -$3.15K |
|
|
AUROW
7830
Aurora Innovation Warrant
AUROW
$370M
| $11K | ﹤0.01% |
7,443
+6,968
| +1,467% | +$10.4K |
|
7831
Banco Macro
BMA
$5.93B
| $11K | ﹤0.01% |
673
-2,888
| -81% | -$45.7K |
|
7832
BlueLinx
BXC
$471M
| $11K | ﹤0.01% |
230
-1,234
| -84% | -$62K |
|
|
CEPU
7833
Central Puerto
CEPU
$2.24B
| $11K | ﹤0.01% |
3,675
+1,110
| +43% | +$2.96K |
|
7834
ClearSign Technologies
CLIR
$25M
| $11K | ﹤0.01% |
533
+357
| +203% | +$12K |
|
7835
Cellectar Biosciences
CLRB
$21.3M
| $11K | ﹤0.01% |
38
| – | – |
|
|
CNTB
7836
Connect Biopharma Holdings
CNTB
$124M
| $11K | ﹤0.01% |
+435
| New | +$9.84K |
|
7837
China Pharma Holdings
CPHI
$46.2M
| $11K | ﹤0.01% |
39
+8
| +26% | +$2.84K |
|
7838
AdvisorShares Focused Equity ETF
CWS
$131M
| $11K | ﹤0.01% |
239
-935
| -80% | -$44.8K |
|
7839
Sprinklr
CXM
$1.53B
| $11K | ﹤0.01% |
619
-1,581
| -72% | -$29.5K |
|
7840
Cyclerion Therapeutics
CYCN
$15.1M
| $11K | ﹤0.01% |
177
+163
| +1,164% | +$10.7K |
|
7841
Delcath Systems
DCTH
$450M
| $11K | ﹤0.01% |
1,030
+1,028
| +51,400% | +$10.1K |
|
7842
Elutia
ELUT
$38.3M
| $11K | ﹤0.01% |
1,629
-452
| -22% | -$3.69K |
|
7843
Farmmi Inc
FAMI
$5.99M
| $11K | ﹤0.01% |
10
-27
| -73% | -$24.3K |
|
|
FMY
7844
First Trust Mortgage Income Fund
FMY
$48.5M
| $11K | ﹤0.01% |
806
-2,546
| -76% | -$35.3K |
|
|
GIFI
7845
DELISTED
Gulf Island Fabrication
GIFI
| $11K | ﹤0.01% |
2,733
+1,792
| +190% | +$7.89K |
|
|
GLBZ
7846
DELISTED
Glen Burnie Bancorp
GLBZ
| $11K | ﹤0.01% |
952
+477
| +100% | +$5.85K |
|
|
GRI
7847
GRI Bio
GRI
$2.55M
| – | – |
0
| – | – |
|
|
GURE
7848
Gulf Resources
GURE
$4.62M
| $11K | ﹤0.01% |
237
+231
| +3,850% | +$11.3K |
|
7849
Solana Company
HSDT
$98.1M
| – | – |
0
| – | – |
|
7850
SeaStar Medical
ICU
$12.8M
| $11K | ﹤0.01% |
4
-8
| -67% | -$19.8K |
|
Similar funds
UBS Group's Q3 2021 Portfolio in Review
As of Q3 2021, UBS Group held 10,865 positions worth $318B, up 2.4% from $310B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group deployed $12.8B of net new capital in Q3 2021, opening 1,329 new positions and adding to 3,996 existing holdings. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 1,947,829 shares worth $50.4M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $626M trimmed.
- UBS Group's largest Q3 2021 buy was Dimensional World ex US Core Equity 2 ETF: 1,947,829 shares worth $50.4M.
- UBS Group added most to Apple in Q3 2021, an estimated $541M increase.
- UBS Group's biggest Q3 2021 reduction was Invesco QQQ Trust, cutting an estimated $626M.
- UBS Group fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $282M.
- UBS Group's ten largest holdings make up 14% of its $318B portfolio in Q3 2021.
- UBS Group opened 1,329 new positions and closed 1,130 in Q3 2021.
- UBS Group's portfolio value rose 2.4% quarter-over-quarter to $318B.
Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.